株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

臨床試験支援サービスの世界市場:成長、動向、および予測

Clinical Trials Support Services Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 391379
出版日 ページ情報 英文 113 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
臨床試験支援サービスの世界市場:成長、動向、および予測 Clinical Trials Support Services Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年09月01日 ページ情報: 英文 113 Pages
概要

当レポートは世界の臨床試験支援サービス市場について調査しており、市場機会や動向、成長および阻害要因、フェーズ・サービスタイプ・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の仮定
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 成長要因
  • 阻害要因
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内の競争

第5章 市場セグメント

  • フェーズ別
    • 前臨床試験
    • フェーズI
    • フェーズII
    • フェーズIII
    • フェーズIV
  • サービスタイプ別
    • 臨床試験サイト管理
    • 被験者募集管理
    • アッセイ開発
    • 臨床研究
    • 受託製造
    • 包装、保管、流通サービス
    • 商業化
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ地域
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Charles River Laboratories Intl Inc.
    • Eurofins Scientific SE
    • Laboratory Corp. of America Holdings
    • The Pharmaceutical Product Development LLC
    • ALcura
    • Insight Genetics
    • Parexel International
    • Icon PLC
    • IQVIA
    • WuXi AppTec

第7章 市場機会および将来動向

目次
Product Code: 50428

Market Overview

The clinical trials support services market will show rapid growth due to the demand for clinical trials in the emerging markets, high R&D spending of the pharmaceutical industry and the increasing number of CROs and prevalence of diseases.

In emerging countries, there are numerous unmet needs of clinical trials for novel drugs, due to the increasing prevalence of infectious and tropical diseases in the region. The number of individuals suffering from insulin resistance, hyperlipidemia, and obesity is increasing rapidly in these regions and, the cost of conducting clinical trials is relatively cheaper, due to fewer labor costs and low costs for handling clinical trial supplies. Thus the demand for clinical trials in emerging countries is expected to drive the clinical trials support services market's growth over the forecast period.

The research and development (R&D) spending of pharmaceutical companies has also been steadily increasing over the past few years. This was mainly due to numerous patent expiries, and as a result of the patent expiration, there are many pharmaceutical companies that will have no other option but to develop new revolutionary molecules for survival. Therefore, the companies are spending more on R&D to accelerate the development of drugs through clinical trials, and henceforth increasing the overall market.

Scope of the Report

As per the scope of the report, clinical trial support services are the various services, which pharmaceutical companies use during the clinical trials they conduct, either for the approval of new drug molecules or for the introduction of generics and biosimilars into the market.

Key Market Trends

Phase I is anticipated to be the Growing Segment During the Forecast Period

Clinical trials support services for phase-I include services, like early-phase patient screening, sample collection management, data management, and assay redesign services, among others. The United States, Europe, and China, followed by Canada and Australia are thus found be the major hubs, where a large set of Phase-I clinical trials are being registered and conducted. Thus, it is a major market for clinical trial management services.

Despite the trend of outsourcing, the developing countries host a significantly small fraction of Phase I trials. Thus the increasing number of Investigative New Drug (IND) applications filed and the trend of outsourcing plays a major role in the drug development process.

North America Region Holds the Largest Market Share of Clinical Trials Support Services Market

North America is found to be one of the largest markets for global clinical trials support services owing to the maximum number of pharmaceutical firms based in the United States to conduct most of their business in this region. There are also increasing R&D investments and growing demand for drug development that are the main factors for the growth of the overall market.

Moreover, owing to the trend of clinical trial outsourcing, the clinical trial site management services, for managing offshore operations has witnessed rapid growth.

Competitive Landscape

Product launches, partnerships, collaborations, agreements, and market expansions were the key strategies adopted by players to grow and expand their presence in the clinical trial management system market. The major players include Accovion GmbH, Alcura Health, Charles River Laboratories, Chiltern International Limited, Covance, Inc., ICON PLC, Parexel International, Pharmaceutical Product Development LLC, Pharmnet, Quotient Bioresearch, and WuXi PharmaTech, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Demand for Clinical Trials in the Emerging Markets
    • 4.2.2 High R&D Spending of the Pharmaceutical Industry
    • 4.2.3 Increasing Number of CROs and Prevalence of Diseases
  • 4.3 Market Restraints
    • 4.3.1 Lack of Adequate Regulatory Framework for Conducting Clinical Trials in some Countries
    • 4.3.2 Stringent Regulations for Patient Enrollment
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Phase
    • 5.1.1 Preclinical Studies
    • 5.1.2 Phase I
    • 5.1.3 Phase II
    • 5.1.4 Phase III
    • 5.1.5 Phase IV
  • 5.2 By Service Type
    • 5.2.1 Clinical Trial Site Management
    • 5.2.2 Patient Recruitment Management
    • 5.2.3 Assay Development
    • 5.2.4 Clinical Research
    • 5.2.5 Contract Manufacturing
    • 5.2.6 Packaging, Storage and Distribution Services
    • 5.2.7 Commercialization
    • 5.2.8 Other Service Types
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Charles River Laboratories Intl Inc.
    • 6.1.2 Eurofins Scientific SE
    • 6.1.3 Laboratory Corp. of America Holdings
    • 6.1.4 The Pharmaceutical Product Development LLC
    • 6.1.5 ALcura
    • 6.1.6 Insight Genetics
    • 6.1.7 Parexel International
    • 6.1.8 Icon PLC
    • 6.1.9 IQVIA
    • 6.1.10 WuXi AppTec

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top